Skip to Content

TEMOZOLOMIDE 250 mg (Temozolomide 250 mg)

Pill with imprint TEMOZOLOMIDE 250 mg is White, Capsule-shape and has been identified as Temozolomide 250 mg. It is supplied by Sandoz Inc..

Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma; anaplastic oligodendroglioma; melanoma; melanoma, metastatic and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEMOZOLOMIDE 250 mg

Temozolomide

Imprint:
TEMOZOLOMIDE 250 mg
Strength:
250 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Alkylating agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Sandoz Inc.
National Drug Code (NDC):
00781-2696

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide